Showing results (151-160 of 527) with videos related to

Sort By:
Pageof 53
Blood|August 7, 2020
Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractorinessMohamad Mohty, Ernst Holler, Madan Jagasia, et al.
Bone Marrow Transplantation|November 6, 2024
Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host diseaseZahra Mahmoudjafari, Valkal Bhatt, John Galvin, et al.
Haematologica|July 2, 2026
NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathwayEri Matsuki, Masahiro Miyata, Ryo Sato, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2013
PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6Yaping Sun, John Sun, Toubai Tomomi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2011
Host basophils are dispensable for induction of donor T helper 2 cell differentiation and severity of experimental graft-versus-host diseaseIsao Tawara, Evelyn Nieves, Chen Liu, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|April 27, 2004
Infliximab in the treatment of ulcerative colitis with toxic megacolonParupudi V J Sriram, K S Pavan Reddy, Guduru V Rao, et al.
Blood|March 31, 2005
Critical role of host gammadelta T cells in experimental acute graft-versus-host diseaseYoshinobu Maeda, Pavan Reddy, Kathleen P Lowler, et al.
ACS Omega|September 18, 2023
Tale of Twin Bifunctional Second Messenger (p)ppGpp Synthetases and Their Function in MycobacteriaShubham Kumar Sinha, Neethu Rs, Yogeshwar Devarakonda, et al.
BMC Cancer|November 21, 2018
Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)Nikolas von Bubnoff, Gabriele Ihorst, Olga Grishina, et al.
Annals of Hematology|March 23, 2021
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCTHenning Schäfer, Jacqueline Blümel-Lehmann, Gabriele Ihorst, et al.
Pageof 53